Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Akorn launches generic cromolyn sodium

May 12, 1998

VISX Excimer Laser System approved in Japan

May 11, 1998

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

First market introduction for Alcon's newest ophthalmic drug

May 5, 1998

Update on Repligen's angiogenesis inhibitors

May 1, 1998

CyDex and Allergan sign option for ophthalmic drug delivery technology

April 29, 1998

New antiglaucoma agent approved in U.S.

April 24, 1998

Another European launch for Alphagan

April 23, 1998

Akorn acquires ophthalmic products from Alza

April 20, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...